"We are pleased to strengthen our ongoing collaboration with Merck to assist with data standards management and to expand the value of the Pinnacle 21 platform,” said William F. Feehery, Chief Executive Officer. “Merck is a premier research-intensive company, and our teams are well-aligned in the goal of delivering high-quality research data faster to help save and improve lives around the world.”
关于Certara
Certara 致力于通过生物模拟软件、技术和服务加速药物研发，改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 66 个国家的监管机构。了解更多信息，请访问 www.certara.com.cn。
Certara 联系人:
Sheila Rocchio
[email protected]
媒体联系人：
Alyssa Horowitz
[email protected]
